Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel elemental sulfur-promoted synthesis avoids peroxides and heavy metals. Cost-effective, scalable route for high-purity pharmaceutical intermediates ensuring supply chain reliability.
Novel nickel-catalyzed method reduces costs and improves safety for 2-pyrrolidone derivatives manufacturing ensuring reliable supply chain continuity.
Patent CN110467555B reveals a novel chiral phosphoric acid catalyzed method for synthesizing axially chiral indoles with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN111705329B details a green electrochemical route for 5-arylthiouracil. Eliminates oxidants, uses electrons, offers high yield and easy purification for pharma intermediates.
Patent CN112778352B details a novel Pd-catalyzed ortho-C-H silylation method. This route offers high atom economy and streamlined supply chains for pharmaceutical intermediates.
Patent CN115260080B reveals a one-step palladium-catalyzed carbonylation route. This method offers significant supply chain stability and cost optimization for pharmaceutical intermediates.
Patent CN116239623B reveals low-catalyst borate ester synthesis enabling high-purity pharmaceutical intermediate manufacturing with significant supply chain cost optimization.
Novel metal-free synthesis method for high-purity azaspiro intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing processes
Patent CN114920775B introduces a novel axial chiral bisindole catalyst offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN114751883B reveals a Pd-catalyzed carbonylation route. Delivers cost-effective, scalable production for high-purity pharmaceutical intermediates.
Novel patent CN111978194A details a safe carbonylation method using benzyl formate. Offers cost-effective routes for high-purity pharmaceutical intermediates with simplified supply chains.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles disclosed in CN110467579B. Cost-effective, scalable route for API intermediates without heavy metals.
Novel FeX3 catalyzed method for pyrroles replaces noble metals. High purity, green chemistry, and cost-effective solutions for API manufacturing.
Novel mild method for alpha-aryl nitriles using aryl sulfoxides and tin reagents. High yield, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN118515639A reveals efficient Pd-catalyzed route. Offers significant cost reduction and supply reliability for high purity pharma intermediates manufacturing.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Novel room-temperature synthesis of trifluoromethyl 1,2,4-triazines via sulfur ylide cycloaddition. Offers cost reduction in API manufacturing and scalable production.
Novel Pd-catalyzed carbonylation method avoids toxic thiols. High yield, scalable process for reliable pharmaceutical intermediate supply chains.
Patent CN114195711B reveals a novel Pd-catalyzed carbonylation route for quinoline-4(1H)-ones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114195726B reveals a CuCl-catalyzed route for high-purity arylamine compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.